Our People Make The Difference

Biophor was cofounded by Henry Tom, Laura Colin and Dr. Todd Corneillie.
Mr. Tom and Ms. Colin also cofounded Biostride, Forefront Diagnostics and
Venture Labs. The senior management team has over 90 years of in vitro
diagnostic product research and development experience.

Dr. Todd Corneillie
received a Ph.D. in Chemistry from University of California, Davis. Dr. Corneillie’s accomplishments include Vice President of Research and Development, Lumiphore, Inc.; Research Director, Biostride, Inc. and President, Biophor Diagnostics, Inc. He is a co-author of numerous publications and patents, issued and pending, and is a co-inventor of the technology used in Biophor’s assay products.
Dr. Nathan Butlin
received a Ph.D. in Chemistry from the University of California, Davis. Dr. Butlin’s expertise includes work in protein conjugation, lanthanide chelation chemistry and immunoassay development. He has co-authored multiple papers and been co-inventor on issued and pending patents. He is Biophor’s Director of Operations.
Biophor Innovation Learn more...